Dicerna Pharmaceuticals, Inc.
(NASDAQ : DRNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.41%201.631.2%$403.74m
GILDGilead Sciences, Inc.
-0.50%72.420.9%$392.52m
CELGCelgene Corporation
0.47%87.611.2%$340.73m
BIIBBiogen Inc.
0.12%334.811.2%$274.30m
ILMNIllumina, Inc.
0.95%350.503.5%$254.63m
REGNRegeneron Pharmaceuticals, Inc.
-1.27%381.582.6%$207.57m
EXASExact Sciences Corporation
-1.09%72.5325.3%$196.51m
VRTXVertex Pharmaceuticals Incorporated
0.38%176.471.9%$160.48m
SRPTSarepta Therapeutics, Inc.
-0.64%151.3816.4%$124.07m
AAgilent Technologies, Inc.
-0.59%68.671.5%$120.77m
ALXNAlexion Pharmaceuticals, Inc.
0.88%118.852.0%$108.44m
ALNYAlnylam Pharmaceuticals, Inc
0.12%93.479.7%$95.94m
NKTRNektar Therapeutics
-0.84%57.825.6%$95.16m
BMRNBioMarin Pharmaceutical Inc.
0.03%98.184.4%$90.71m
INCYIncyte Corporation
0.54%67.382.5%$88.18m

Company Profile

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases using its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James C. Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.